Published in J Comput Assist Tomogr on September 15, 2005
Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia (2009) 7.44
Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. Magn Reson Imaging (2006) 2.69
Diffusion-weighted magnetic resonance imaging and its application to cancer. Cancer Imaging (2006) 1.91
Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging. Radiology (2010) 1.86
Value of diffusion-weighted MRI in the differentiation of benign and malign breast lesions. Wien Klin Wochenschr (2011) 1.79
The role of diffusion-weighted imaging and the apparent diffusion coefficient (ADC) values for breast tumors. Korean J Radiol (2007) 1.59
Extracranial applications of diffusion-weighted magnetic resonance imaging. Eur Radiol (2007) 1.55
Inflammatory breast cancer: what we know and what we need to learn. Oncologist (2012) 1.41
Quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesion. Eur Radiol (2007) 1.36
Meta-analysis of quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesions. BMC Cancer (2010) 1.26
Breast tumor xenografts: diffusion-weighted MR imaging to assess early therapy with novel apoptosis-inducing anti-DR5 antibody. Radiology (2008) 1.20
Correlation of the apparent diffusion coefficiency values on diffusion-weighted imaging with prognostic factors for breast cancer. Br J Radiol (2011) 1.17
The role of the ADC value in the characterisation of renal carcinoma by diffusion-weighted MRI. Br J Radiol (2009) 1.15
The value of diffusion-weighted imaging in assessing the ADC changes of tissues adjacent to breast carcinoma. BMC Cancer (2009) 1.15
Nonmalignant breast lesions: ADCs of benign and high-risk subtypes assessed as false-positive at dynamic enhanced MR imaging. Radiology (2012) 1.07
FDG PET/CT and diffusion-weighted imaging for breast cancer: prognostic value of maximum standardized uptake values and apparent diffusion coefficient values of the primary lesion. Eur J Nucl Med Mol Imaging (2010) 1.07
Diffusion-weighted imaging (DWI) in MR mammography (MRM): clinical comparison of echo planar imaging (EPI) and half-Fourier single-shot turbo spin echo (HASTE) diffusion techniques. Eur Radiol (2009) 1.05
Significance of breast lesion descriptors in the ACR BI-RADS MRI lexicon. Cancer (2009) 1.02
MRI-only lesions: application of diffusion-weighted imaging obviates unnecessary MR-guided breast biopsies. Eur Radiol (2014) 1.02
Diffusion-weighted MR imaging with background body signal suppression (DWIBS) for the diagnosis of malignant and benign breast lesions. Eur Radiol (2009) 0.99
Diffusion tensor magnetic resonance imaging of the breast: a pilot study. Eur Radiol (2010) 0.99
Characterization of ductal carcinoma in situ on diffusion weighted breast MRI. Eur Radiol (2011) 0.98
Multiparametric magnetic resonance imaging, spectroscopy and multinuclear (²³Na) imaging monitoring of preoperative chemotherapy for locally advanced breast cancer. Acad Radiol (2010) 0.98
The role of mean diffusivity (MD) as a predictive index of the response to chemotherapy in locally advanced breast cancer: a preliminary study. Eur Radiol (2009) 0.95
Diffusion-weighted imaging and FDG PET/CT: predicting the prognoses with apparent diffusion coefficient values and maximum standardized uptake values in patients with invasive ductal carcinoma. World J Surg Oncol (2012) 0.95
Sensitivity and specificity of unenhanced MR mammography (DWI combined with T2-weighted TSE imaging, ueMRM) for the differentiation of mass lesions. Eur Radiol (2009) 0.93
Combined reading of Contrast Enhanced and Diffusion Weighted Magnetic Resonance Imaging by using a simple sum score. Eur Radiol (2015) 0.92
Diffusion weighted magnetic resonance imaging of the breast: protocol optimization, interpretation, and clinical applications. Magn Reson Imaging Clin N Am (2013) 0.91
Detection of non-palpable breast cancer in asymptomatic women by using unenhanced diffusion-weighted and T2-weighted MR imaging: comparison with mammography and dynamic contrast-enhanced MR imaging. Eur Radiol (2010) 0.91
Magnetic resonance imaging in breast cancer: A literature review and future perspectives. World J Clin Oncol (2014) 0.90
The role of parallel diffusion-weighted imaging and apparent diffusion coefficient (ADC) map values for evaluating breast lesions: preliminary results. Acad Radiol (2010) 0.87
Case of the season: a giant fibroadenoma in the guise of a phyllodes tumor; characterization role of MRI. Semin Roentgenol (2009) 0.85
Motion correction in diffusion-weighted MRI of the breast at 3T. J Magn Reson Imaging (2011) 0.85
Correlation of ADC value with pathologic indexes in colorectal tumor homografts in Balb/c mouse. Chin J Cancer Res (2014) 0.85
MR scanner systems should be adequately characterized in diffusion-MRI of the breast. PLoS One (2014) 0.84
Whole-body diffusion-weighted and proton imaging: a review of this emerging technology for monitoring metastatic cancer. Semin Roentgenol (2009) 0.84
Clinical potential of an antitumor drug sensitivity test and diffusion-weighted MRI in a patient with a recurrent solid pseudopapillary tumor of the pancreas. J Gastroenterol (2007) 0.84
MRI methods for evaluating the effects of tyrosine kinase inhibitor administration used to enhance chemotherapy efficiency in a breast tumor xenograft model. J Magn Reson Imaging (2009) 0.83
Molecular Imaging in Breast Cancer - Potential Future Aspects. Breast Care (Basel) (2011) 0.83
Conspicuity of breast lesions at different b values on diffusion-weighted imaging. BMC Cancer (2012) 0.83
Differential diagnosis of benign and malignant breast masses using diffusion-weighted magnetic resonance imaging. World J Surg Oncol (2015) 0.83
Early therapy assessment of combined anti-DR5 antibody and carboplatin in triple-negative breast cancer xenografts in mice using diffusion-weighted imaging and (1)H MR spectroscopy. J Magn Reson Imaging (2013) 0.82
Qualitative and quantitative diffusion-weighted imaging of the breast at 3T - A useful adjunct to contrast-enhanced MRI in characterization of breast lesions. Indian J Radiol Imaging (2016) 0.81
Characterization of breast tumors using diffusion kurtosis imaging (DKI). PLoS One (2014) 0.80
Computer aided-diagnosis of prostate cancer on multiparametric MRI: a technical review of current research. Biomed Res Int (2014) 0.80
Molecular imaging of water binding state and diffusion in breast cancer using diffuse optical spectroscopy and diffusion weighted MRI. J Biomed Opt (2012) 0.78
Diffusion-weighted imaging of breast tumours at 3 Tesla and 7 Tesla: a comparison. Eur Radiol (2015) 0.77
Diffusion-weighted magnetic resonance imaging for assessment after neoadjuvant chemotherapy in breast cancer, based on morphological concepts. Oncol Lett (2010) 0.77
Diffusion-weighted imaging: Effects of intravascular contrast agents on apparent diffusion coefficient measures of breast malignancies at 3 Tesla. J Magn Reson Imaging (2015) 0.76
Magnetic resonance in the detection of breast cancers of different histological types. Magn Reson Insights (2013) 0.76
Brain extraction in pediatric ADC maps, toward characterizing neuro-development in multi-platform and multi-institution clinical images. Neuroimage (2015) 0.76
The Efficiency of Diffusion Weighted MRI and MR Spectroscopy On Breast MR Imaging. J Breast Health (2013) (2014) 0.75
Intravoxel incoherent motion diffusion-weighted imaging for monitoring chemotherapeutic efficacy in gastric cancer. World J Gastroenterol (2016) 0.75
A Metric for Reducing False Positives in the Computer-Aided Detection of Breast Cancer from Dynamic Contrast-Enhanced Magnetic Resonance Imaging Based Screening Examinations of High-Risk Women. J Digit Imaging (2016) 0.75
Analysis of factors influencing the degree of detectability on diffusion-weighted MRI and diffusion background signals in patients with invasive breast cancer. Medicine (Baltimore) (2016) 0.75
Diagnostic performance of ADCs in different ROIs for breast lesions. Int J Clin Exp Med (2015) 0.75
Texture analysis on MR images helps predicting non-response to NAC in breast cancer. BMC Cancer (2015) 0.75
The distribution of the apparent diffusion coefficient as an indicator of the response to chemotherapeutics in ovarian tumour xenografts. Sci Rep (2017) 0.75
Feasibility of single-voxel MRS measurement of apparent diffusion coefficient of water in breast tumors. Magn Reson Med (2009) 0.75
Apparent diffusion coefficient value in invasive ductal carcinoma at 3.0 Tesla: is it correlated with prognostic factors? Br J Radiol (2016) 0.75
Additional Value of Diffusion-Weighted Imaging to Evaluate Prognostic Factors of Breast Cancer: Correlation with the Apparent Diffusion Coefficient. Iran J Radiol (2016) 0.75
An acetone-based phantom for quantitative diffusion MRI. J Magn Reson Imaging (2017) 0.75
Diffusion-weighted imaging of breast lesions: Region-of-interest placement and different ADC parameters influence apparent diffusion coefficient values. Eur Radiol (2016) 0.75
Accuracy of diffusion kurtosis imaging in characterization of breast lesions. Br J Radiol (2017) 0.75
Reorganization of the somatosensory cortex in hemiplegic cerebral palsy associated with impaired sensory tracts. Neuroimage Clin (2017) 0.75
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet (2009) 8.11
Endocannabinoid-mediated control of synaptic transmission. Physiol Rev (2009) 5.56
Requirement for hippocampal CA3 NMDA receptors in associative memory recall. Science (2002) 4.78
Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer (2004) 4.54
Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol (2007) 3.91
Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys (2010) 3.66
The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission. Neuron (2010) 3.28
Results of a multicenter study of 1,057 cases of rectal cancer treated by laparoscopic surgery. Surg Endosc (2008) 2.88
Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study). Lancet Oncol (2010) 2.73
Ptf1a, a bHLH transcriptional gene, defines GABAergic neuronal fates in cerebellum. Neuron (2005) 2.66
The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J Neurosci (2006) 2.66
Complementary roles of cholecystokinin- and parvalbumin-expressing GABAergic neurons in hippocampal network oscillations. J Neurosci (2005) 2.64
Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys (2007) 2.56
Release probability of hippocampal glutamatergic terminals scales with the size of the active zone. Nat Neurosci (2012) 2.49
Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial. Lancet Oncol (2013) 2.45
Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. J Neurosci (2007) 2.32
Cbln1 is essential for synaptic integrity and plasticity in the cerebellum. Nat Neurosci (2005) 2.29
Oligometastases and oligo-recurrence: the new era of cancer therapy. Jpn J Clin Oncol (2010) 2.17
Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1. J Biol Chem (2004) 2.17
Open versus laparoscopic resection of primary tumor for incurable stage IV colorectal cancer: a large multicenter consecutive patients cohort study. Ann Surg (2012) 2.12
Laparoscopy-assisted pancreas- and spleen-preserving total gastrectomy for gastric cancer as compared with open total gastrectomy. Surg Endosc (2009) 2.12
ADC mapping of benign and malignant breast tumors. Magn Reson Med Sci (2005) 2.02
Distinct functions of kainate receptors in the brain are determined by the auxiliary subunit Neto1. Nat Neurosci (2011) 2.00
SK2 channel plasticity contributes to LTP at Schaffer collateral-CA1 synapses. Nat Neurosci (2008) 1.97
T-type Ca2+ channels, SK2 channels and SERCAs gate sleep-related oscillations in thalamic dendrites. Nat Neurosci (2008) 1.79
Reversible brain atrophy in anti-NMDA receptor encephalitis: a long-term observational study. J Neurol (2010) 1.72
Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2-mediated direct suppression and M1/M3-mediated indirect suppression through endocannabinoid signalling. Eur J Neurosci (2004) 1.71
Identity, distribution, and development of polydendrocytes: NG2-expressing glial cells. J Neurocytol (2003) 1.70
Subtype switching of vesicular glutamate transporters at parallel fibre-Purkinje cell synapses in developing mouse cerebellum. Eur J Neurosci (2003) 1.68
Cbln1 is a ligand for an orphan glutamate receptor delta2, a bidirectional synapse organizer. Science (2010) 1.65
Autoantibodies and cell-mediated autoimmunity to NMDA-type GluRepsilon2 in patients with Rasmussen's encephalitis and chronic progressive epilepsia partialis continua. Epilepsia (2005) 1.65
Tumor budding as an index to identify high-risk patients with stage II colon cancer. Dis Colon Rectum (2008) 1.61
Aberrant membranes and double-membrane structures accumulate in the axons of Atg5-null Purkinje cells before neuronal death. Autophagy (2007) 1.61
Functional differences between neurochemically defined populations of inhibitory interneurons in the rat spinal dorsal horn. Pain (2013) 1.59
RGS2 modulates coupling between GABAB receptors and GIRK channels in dopamine neurons of the ventral tegmental area. Nat Neurosci (2007) 1.58
EGFR genetic heterogeneity of nonsmall cell lung cancers contributing to acquired gefitinib resistance. Int J Cancer (2008) 1.55
Predominant expression of phospholipase Cbeta1 in telencephalic principal neurons and cerebellar interneurons, and its close association with related signaling molecules in somatodendritic neuronal elements. Eur J Neurosci (2008) 1.54
Retention of NMDA receptor NR2 subunits in the lumen of endoplasmic reticulum in targeted NR1 knockout mice. Proc Natl Acad Sci U S A (2003) 1.53
Presynaptically released Cbln1 induces dynamic axonal structural changes by interacting with GluD2 during cerebellar synapse formation. Neuron (2012) 1.52
Accumulation of AMPA receptors in autophagosomes in neuronal axons lacking adaptor protein AP-4. Neuron (2008) 1.52
Trehalose transporter 1, a facilitated and high-capacity trehalose transporter, allows exogenous trehalose uptake into cells. Proc Natl Acad Sci U S A (2007) 1.52
Genetics of synchronous uterine and ovarian endometrioid carcinoma: combined analyses of loss of heterozygosity, PTEN mutation, and microsatellite instability. Hum Pathol (2002) 1.51
Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors. J Neurosci (2013) 1.48
Segmental motor paralysis after expansive open-door laminoplasty. Spine (Phila Pa 1976) (2002) 1.47
Multi-institutional study of radiation therapy for isolated para-aortic lymph node recurrence in uterine cervical carcinoma: 84 subjects of a population of more than 5,000. Int J Radiat Oncol Biol Phys (2006) 1.45
Anastomotic leakage contributes to the risk for systemic recurrence in stage II colorectal cancer. J Gastrointest Surg (2010) 1.44
Linear fractures occult on skull radiographs: a pitfall at radiological screening for mild head injury. J Trauma (2011) 1.44
Translocation of a "winner" climbing fiber to the Purkinje cell dendrite and subsequent elimination of "losers" from the soma in developing cerebellum. Neuron (2009) 1.43
GABAergic basket cells expressing cholecystokinin contain vesicular glutamate transporter type 3 (VGLUT3) in their synaptic terminals in hippocampus and isocortex of the rat. Eur J Neurosci (2004) 1.42
Left-right asymmetry of the hippocampal synapses with differential subunit allocation of glutamate receptors. Proc Natl Acad Sci U S A (2008) 1.42
Laparoscopy-assisted distal gastrectomy for early gastric cancer with complete situs inversus: report of a case. Surg Today (2009) 1.40
Prospective ten-year follow-up study comparing patients with whiplash-associated disorders and asymptomatic subjects using magnetic resonance imaging. Spine (Phila Pa 1976) (2010) 1.40
Peripheral, but not central, CB1 antagonism provides food intake-independent metabolic benefits in diet-induced obese rats. Diabetes (2008) 1.39
Tripartite motif-containing 29 (TRIM29) is a novel marker for lymph node metastasis in gastric cancer. Ann Surg Oncol (2007) 1.38
Cytodifferentiation of Bergmann glia and its relationship with Purkinje cells. Anat Sci Int (2002) 1.38
Three types of neurochemical projection from the bed nucleus of the stria terminalis to the ventral tegmental area in adult mice. J Neurosci (2012) 1.38
Functional coupling between mGluR1 and Cav3.1 T-type calcium channels contributes to parallel fiber-induced fast calcium signaling within Purkinje cell dendritic spines. J Neurosci (2009) 1.36
JGES guidelines for colorectal endoscopic submucosal dissection/endoscopic mucosal resection. Dig Endosc (2015) 1.35
Preferential localization of muscarinic M1 receptor on dendritic shaft and spine of cortical pyramidal cells and its anatomical evidence for volume transmission. J Neurosci (2010) 1.35
Spinal endocannabinoids and CB1 receptors mediate C-fiber-induced heterosynaptic pain sensitization. Science (2009) 1.34
Spinocerebellar ataxia type 6 knockin mice develop a progressive neuronal dysfunction with age-dependent accumulation of mutant CaV2.1 channels. Proc Natl Acad Sci U S A (2008) 1.34
NR3A-containing NMDARs promote neurotransmitter release and spike timing-dependent plasticity. Nat Neurosci (2011) 1.33
CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance. Cell Metab (2010) 1.33
NR2B tyrosine phosphorylation modulates fear learning as well as amygdaloid synaptic plasticity. EMBO J (2006) 1.32
Downregulation of the CB1 cannabinoid receptor and related molecular elements of the endocannabinoid system in epileptic human hippocampus. J Neurosci (2008) 1.32
Immunolocalization of metabotropic glutamate receptor 1alpha (mGluR1alpha) in distinct classes of interneuron in the CA1 region of the rat hippocampus. Hippocampus (2004) 1.32
Short-term surgical outcomes from a randomized controlled trial to evaluate laparoscopic and open D3 dissection for stage II/III colon cancer: Japan Clinical Oncology Group Study JCOG 0404. Ann Surg (2014) 1.32
Fyn kinase-mediated phosphorylation of NMDA receptor NR2B subunit at Tyr1472 is essential for maintenance of neuropathic pain. Eur J Neurosci (2005) 1.32
Dehydration-induced expression of LEA proteins in an anhydrobiotic chironomid. Biochem Biophys Res Commun (2006) 1.31
Aging of the cervical spine in healthy volunteers: a 10-year longitudinal magnetic resonance imaging study. Spine (Phila Pa 1976) (2009) 1.30
Synaptic distribution of the NR1, NR2A and NR2B subunits of the N-methyl-d-aspartate receptor in the rat lumbar spinal cord revealed with an antigen-unmasking technique. Eur J Neurosci (2004) 1.29
Diffusion-weighted imaging of the breast: principles and clinical applications. Radiographics (2011) 1.29
Number and density of AMPA receptors in individual synapses in the rat cerebellum as revealed by SDS-digested freeze-fracture replica labeling. J Neurosci (2007) 1.28
Axonal motility and its modulation by activity are branch-type specific in the intact adult cerebellum. Neuron (2007) 1.28
Disturbance of cerebellar synaptic maturation in mutant mice lacking BSRPs, a novel brain-specific receptor-like protein family. FEBS Lett (2006) 1.28
Vitrification is essential for anhydrobiosis in an African chironomid, Polypedilum vanderplanki. Proc Natl Acad Sci U S A (2008) 1.27
Imaging extrasynaptic glutamate dynamics in the brain. Proc Natl Acad Sci U S A (2010) 1.27
Signaling complex formation of phospholipase Cbeta4 with metabotropic glutamate receptor type 1alpha and 1,4,5-trisphosphate receptor at the perisynapse and endoplasmic reticulum in the mouse brain. Eur J Neurosci (2004) 1.26
Identification of residual breast carcinoma following neoadjuvant chemotherapy: diffusion-weighted imaging--comparison with contrast-enhanced MR imaging and pathologic findings. Radiology (2010) 1.26
Targeted disruption of the mouse 3-phosphoglycerate dehydrogenase gene causes severe neurodevelopmental defects and results in embryonic lethality. J Biol Chem (2003) 1.26
Spatial diversity in gene expression for VDCCgamma subunit family in developing and adult mouse brains. Neurosci Res (2005) 1.25
Endovascular surgery for very small ruptured intracranial aneurysms. Technical note. J Neurosurg (2006) 1.25
Abundant distribution of TARP gamma-8 in synaptic and extrasynaptic surface of hippocampal neurons and its major role in AMPA receptor expression on spines and dendrites. Eur J Neurosci (2006) 1.24
Optimization of oligodendrocyte progenitor cell culture method for enhanced survival. J Neurosci Methods (2005) 1.24
Selective reduction of a PDZ protein, SAP-97, in the prefrontal cortex of patients with chronic schizophrenia. J Neurochem (2002) 1.24
Unique inhibitory synapse with particularly rich endocannabinoid signaling machinery on pyramidal neurons in basal amygdaloid nucleus. Proc Natl Acad Sci U S A (2011) 1.23
Lymph node metastasis density and growth pattern as independent prognostic factors in advanced esophageal squamous cell carcinoma. World J Surg (2007) 1.23